Search

everythinglearnresearchcommunity

for

Search:↓

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Intralesional cidofovir might be a good alternative treatment.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Cancer myths can harm treatment and prevention efforts.

Patients with Complete Androgen Insensitivity Syndrome need psychological support and multidisciplinary care for complex treatment decisions.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Pregnancy and parenthood may help regulate PCOS symptoms.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Nanotechnology improves Clomiphene citrate's effectiveness and reduces side effects for treating ovulatory disorders.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Vitamin D supplements increased ovulation rates in women with PCOS who were vitamin D deficient.

Some blood donors on teratogenic drugs may have unsafe drug levels, suggesting a need for better deferral policies.

Low zinc levels may be linked to the return of gynecologic cancers.

Lifestyle changes improve reproductive function and hormonal balance in obese women with PCOS.

Some birth control pills can cause temporary or more serious hair loss.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

Postmenopausal virilization can be caused by ovarian hyperthecosis, treatable with surgery.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

A mare had a functional ovary with a tumor containing cartilage and bone.

Scalp cooling and minoxidil can help manage hair loss after chemotherapy.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Financial support and better counseling are needed to make chemotherapy more affordable and manageable for women in Pakistan.

PCOS is influenced by genetics and lifestyle, causing hormonal imbalances and health risks like diabetes and infertility.

Pesticides can cause reproductive and adrenal health issues.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Human placenta helps hair grow back after chemotherapy by blocking cell death and increasing hair follicle growth.